Many years of the company’s experience have allowed to create a wide network of partner companies and reliable service providers, among them those manufacturing pharmaceutical companies which are necessary for high-quality development and manufacturing of preparations for humans.
MC-Development was created in 2014 with registration in the Russian Innovations Center of Skolkovo as a Resident Company.
During the years of its work, the company has made its contribution to putting about 12 pharmaceuticals on the market. Starting from 2017 and up to the present day, the company’s operations have been connected with active attraction of new projects, and, as a result, there are 6 active projects in the portfolio at various stages of development. The projects are related to development of preparations for treatment of diabetes, obesity, Alzheimer disease, gastric ulcer, lipid metabolic imbalances. The work of evaluating prospects of inclusion of new projects into the company’s portfolio goes on, with consideration of arriving project applications from the company’s specialists and from external partner organizations. In 2018, the company became the member of the Consortium under the Center for Scientific and Technological Initiatives at M.M. Shemyakin — Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences